141. Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk.
作者: Woo-Young Shin.;Eun Seok Kang.;Yun Hwan Oh.;Meng Sha.;Qiang Xia.;Seogsong Jeong.;Yoosun Cho.
来源: BMC Gastroenterol. 2025年25卷1期308页
The relationship between the newly proposed steatotic liver disease (SLD) subtypes-metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic alcohol-associated liver disease (MetALD)-and dementia is understudied. We evaluated the dementia risk associated with these subtypes.
142. Endoscopic ultrasound-guided ethanol vs ethanol combined with paclitaxel for the ablation of pancreatic cystic lesions: a systematic review and meta-analysis.
作者: Cong Ding.;Jianfeng Yang.;Jing Yang.;Qiang Liu.;Yishen Mao.;Qi Ding.;Ye Gu.;Xiaofeng Zhang.
来源: BMC Gastroenterol. 2025年25卷1期311页
Some pancreatic cystic lesions (PCLs) have the risk of malignant transformation, but the complications of pancreatic surgery are high, and minimally invasive treatment is imperative. Endoscopic ultrasound (EUS) -guided ablation has been utilized to treat pancreatic cysts. We undertook the meta-analysis and systematic review to assess the efficacy and safety of this technique in PCLs.
143. Prevalence of H. Pylori in inflammatory bowel disease patients and its association with severity.
作者: Abdullah D Alotaibi.;Abdullah A Al-Abdulwahab.;Mona H Ismail.;Jaber M AlElyani.;Turki A Alamri.;Raed M Alsulaiman.;Ibrahim A Alhafid.;Ibrahim M Alzahrani.;Reem S AlSulaiman.;Arwa Althubaity.;Sarah H Buhulaigah.;Abdulaziz A AlQurain.;Abdulaziz M Alrezuk.
来源: BMC Gastroenterol. 2025年25卷1期317页
One key area of interest in gastroenterology research is the relationship between Helicobacter pylori (H. pylori) and Inflammatory bowel disease (IBD). Several studies have shown varying results regarding the prevalence of H. pylori in IBD patients and its impact on disease progression, severity, and overall outcome.
144. Efficacy and safety of Mirikizumab for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials.
作者: Mohamed A Abu Elainein.;Sama S ElSherefy.;Norhan M Yousef.;Sama M ElKady.;Nada G Hamam.;Abdullrahman Elgarawany.;Darin W Aswa.;Ahmed Nour Eldin Hassan.;Salma Allam.
来源: BMC Gastroenterol. 2025年25卷1期307页
Ulcerative colitis (UC) is a widespread incurable chronic inflammation of the colon mucosa. Currently, oral small-molecule medications targeting Janus kinase or sphingosine-1-phosphate and monoclonal antibodies to TNF-α,α4β7 integrins and Ustekinumab are the lines of treatment for UC. Up to 50% of patients either do not react to initial treatment or lose response over time, emphasizing the need for innovative treatment. Mirikizumab, a humanized IgG4-variant monoclonal antibody, binds to subunit p19 of interleukin-23. This systematic review aims to evaluate Mirikizumab compared to placebo in treating moderate-to-severe active UC. Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines and using the Population, Intervention, Comparison, Outcome, Study design (PICOS) model for inclusion and exclusion criteria, we systematically reviewed the literature. Our inclusion criteria encompassed randomized controlled trials assessing Mirikizumab efficacy in treating UC across demographics. We employed the Cochrane Risk of Bias tool (RoB1) to investigate bias within included studies across its seven domains. The statistical analysis was conducted using Review Manager Version 5 software. Four studies were included, comparing patients treated with mirikizumab to placebo groups. All doses of mirikizumab administered intravenously demonstrated clinical remission, specifically, the 200 mg and 300 mg doses showed significant efficacy, with risk ratios of 4.74 (95% CI [1.43, 15.69]) and 1.82 (95% CI [1.33, 2.50]), respectively. During the maintenance phase of extension trials, symptoms subsided with a subcutaneous 200 mg dose (RR = 1.46, 95% CI [0.47, 4.51], P = 0.51). To conclude, mirikizumab demonstrates significant efficacy in treating UC, substaintially improving clinical, endoscopic, and histological outcomes.
145. CA19-9/DBil: a promising indicator to distinguish between CA19-9-elevated pancreatic head-type autoimmune pancreatitis and pancreatic head cancer.
作者: Wenfeng Xi.;Wanying Liao.;Tao Guo.;Qingwei Jiang.;Xiaoyin Bai.;Xi Wu.;Yunlu Feng.;Shengyu Zhang.;Dongsheng Wu.;Qiang Wang.;Aiming Yang.
来源: BMC Gastroenterol. 2025年25卷1期306页
Pancreatic head-type autoimmune pancreatitis (PH-AIP) with elevated CA19-9 is sometimes difficult to distinguish from pancreatic head cancer (PHC) with elevated CA19-9. At times, IgG4 proves inadequate in offering assistance. The study aimed to elucidate the performance of CA19-9/DBil in distinguishing between the two conditions.
146. Unveiling the heterogeneity and immunotherapy potency of tumor-associated neutrophils in the tumor microenvironment of gastric cancer.
作者: Tong-Tong Qi.;Si-Jiang Zhou.;Zhu Yu.;Yong Li.;Jun-Qiang Chen.
来源: BMC Gastroenterol. 2025年25卷1期303页
The differentiation characteristics of neutrophils within the gastric cancer (GC) tumor microenvironment (TME) and their interactions with malignant gastric epithelial cells require further investigation. Furthermore, the therapeutic potential of tumor-associated neutrophils (TANs) in immunotherapy remains inadequately explored.
147. Platelet-to-high-density lipoprotein ratio (PHR) as a predictive biomarker for gastrointestinal cancers: evidence from NHANES.
Gastrointestinal (GI) cancers, including gastric, colorectal, and esophageal cancers, pose a significant global health burden. Despite advancements in diagnostic tools, early detection remains challenging, particularly in low-resource settings. Emerging evidence highlights the platelet-to-high-density lipoprotein ratio (PHR) as a novel biomarker integrating systemic inflammation and lipid metabolism. However, its association with GI cancer risk remains underexplored.
148. The prognostic value of sarcopenia in acute-on-chronic liver failure: a systematic review and meta-analysis.
作者: Sike He.;Chang-Hai Liu.;Yuan Wang.;Ziqi Li.;Zhenhua Liu.;Hao Zeng.;Guangxi Sun.
来源: BMC Gastroenterol. 2025年25卷1期300页
Sarcopenia is prevalent in patients with chronic liver diseases, especially in cirrhosis patients. While sarcopenia is identified as a predictor of mortality in cirrhosis, its influence on acute-on-chronic liver failure (ACLF) remains unclear. This systematic review with meta-analysis aimed to explore the prognostic value of sarcopenia in ACLF patients.
149. Emergency pancreatoduodenectomy for non-traumatic conditions: a case series analysis.
作者: Xinxiong Li.;Weixuan Hong.;Zhongdong Zou.;Junhao Du.;Ruohan Su.;Lie Wang.;Chunhong Xiao.;Meiping Wang.
来源: BMC Gastroenterol. 2025年25卷1期301页
Emergency pancreaticoduodenectomy (EPD) is an uncommon abdominal surgical procedure primarily performed in patients with severe acute abdominal trauma. Performing EPD requires strict surgical criteria, advanced technical expertise, and comprehensive postoperative management. Limited research exists regarding the indications for non-traumatic EPD. Thus, the objective of this study was to synthesize and analyze recent cases of non-traumatic EPD, thereby enhancing the comprehension of this urgent surgical measure.
150. Global, regional, and national burden of disease analysis on paralytic ileus and intestinal obstruction in adults aged 65 and over from 1990 to 2021, with projections for 2030: a Global Burden of Disease Study 2021 analysis.
作者: Tao Zhang.;Meng Chen.;Zhitong Yu.;Zhetan Ren.;Ling Wang.;Qi Si.;Xinping Lu.;Siyuan Bu.;Sihong Shen.;Qingyan Wang.;Yongduo Yu.
来源: BMC Gastroenterol. 2025年25卷1期299页
This study aimed to evaluate the burden and trends of paralytic ileus and bowel obstruction in individuals aged ≥ 65 years, offering insights into prevention, treatment, and healthcare policy.
151. Association between platelet-to-high-density lipoprotein cholesterol ratio and gallstone prevalence in the American adult population: a cross-sectional study analysis.
作者: Yongkang Liang.;Xueyi Feng.;Song Liang.;Juhe Zhang.;Changjun Yu.
来源: BMC Gastroenterol. 2025年25卷1期297页
The platelet-to-high-density lipoprotein cholesterol ratio(PHR), a novel marker of inflammatory response and metabolic dysregulation, has been linked to various chronic conditions.This study aimed to evaluate the association between PHR and the prevalence of gallstones.
152. Prevalence and patterns of peptic ulcer disease in Africa: a systematic review and meta-analysis.
Peptic ulcer disease (PUD) remains a significant yet poorly understood public health issue in Africa, despite its declining prevalence in Western countries. Studies from Africa report a highly variable burden, with the highest prevalence observed in West Africa and the lowest in Southern Africa. However, the overall burden of PUD in Africa, its patterns (duodenal ulcers, gastric ulcers, and coexisting ulcers), and its association with H. pylori infection remain unclear.
153. Spatiotemporal trends in hernia disease burden and health workforce correlations in aging populations: a global analysis with projections to 2050.
作者: Fangyi Dai.;Yuzhou Cai.;Huayou Luo.;Ruo Shu.;Tong Zhang.;Yong Dai.
来源: BMC Gastroenterol. 2025年25卷1期296页
Inguinal, femoral, and abdominal wall hernias represent significant health and economic burdens globally, particularly among adults aged 45 and older. In 2021, the Global Burden of Disease Study reported 1.72 million new cases, 6.75 million prevalent cases, and over 41,000 deaths in this population. While age-standardized rates have declined with improved healthcare, absolute burden continues to rise due to population growth and aging. Gender disparities remain pronounced, with men experiencing sevenfold higher incidence than women. This study analyzes global hernia trends, determinants, future projections, and the association between health workforce distribution and hernia burden to inform targeted interventions.
154. Risk prediction and effect evaluation of complicated appendicitis based on XGBoost modeling.
作者: Sunmeng Chen.;Jianfu Xia.;Beibei Xu.;Yi Huang.;Miaomiao Teng.;Juyi Pan.
来源: BMC Gastroenterol. 2025年25卷1期295页
The distinction between complicated appendicitis (CAP) and uncomplicated appendicitis (UAP) remains challenging. The purpose of this study was to construct a safe and economical diagnostic model that can accurately and rapidly differentiate between CAP and UAP.
155. Impact of occupation on survival of esophageal squamous cell carcinoma patients following esophagectomy: a long-term survival analysis.
作者: Kexun Li.;Simiao Lu.;Jie Mao.;Huan Zhang.;Kangning Wang.;Guangyuan Liu.;Qifeng Wang.;Yongtao Han.;Lin Peng.;Xuefeng Leng.
来源: BMC Gastroenterol. 2025年25卷1期293页
Esophageal cancer (EC), particularly esophageal squamous cell carcinoma (ESCC), is a major global health issue with high incidence and mortality rates in Asia. This study examines the impact of occupational background on the long-term survival of ESCC patients following esophagectomy.
156. Transient and persistent small-bowel intussusception in children: a decision tree analysis model based on ultrasound and clinical findings.
To develop a systematic and efficient decision tree analysis (DTA) model to improve the diagnostic accuracy of transient small-bowel intussusception (TSBI) and persistent small-bowel intussusception (PSBI) in children.
157. Independent effects of the hemoglobin-to-red blood cell distribution width ratio on 180-day mortality in critically ill patients with Gastrointestinal bleeding: analysis from the MIMIC-IV database.
作者: Yanling Xiao.;Lixia Liu.;Xiaoying Peng.;Yan Wang.;Zhengwen Xu.
来源: BMC Gastroenterol. 2025年25卷1期290页
Gastrointestinal bleeding (GIB) is associated with high mortality rates among critically ill patients. The hemoglobin-to-red blood cell distribution width ratio (HRR) has recently emerged as a potential prognostic marker in various clinical settings. However, the association between HRR and prognosis in critically ill patients with GIB is unclear.
158. Association of periampullary diverticulum types with post-ERCP hyperamylasemia: a retrospective observational study.
作者: Serdar Akca.;Galip Egemen Atar.;Serkan Ocal.;Osman Cagin Buldukoglu.;Gokhan Koker.;Muhammed Devran Isik.;Besir Kaya.;Hatice Deniz.;Ferda Akbay Harmandar.;Ayhan Hilmi Cekin.
来源: BMC Gastroenterol. 2025年25卷1期284页
This study aimed to assess the prevalence of periampullary diverticulum (PAD) among endoscopic retrograde cholangiopancreatography (ERCP) patients in Southwestern Turkey and investigate the association between the new PAD classification, post-ERCP hyperamylasemia, and post-ERCP pancreatitis (PEP).
159. Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance.
作者: Jinfeng Wang.;Jianfei Shi.;Lili Mi.;Ning Li.;Xin Han.;Man Zhao.;Xiaoling Duan.;Guangjie Han.;Jiaojiao Hou.;Fei Yin.
来源: BMC Gastroenterol. 2025年25卷1期287页
Drug resistance reflects the evolution of tumors and represents the leading factor behind recurrence and death. Lenvatinib is the first-line therapy for hepatocellular carcinoma (HCC), but its effectiveness is limited by rapid development of resistance. Therefore, we aimed to identify lenvatinib resistance-related genes and assess their influence on prognosis and treatment response in HCC.
160. Safety of early feeding after endoscopic ultrasound-guided fine needle biopsy: a retrospective study.
作者: Bo Kyeong Lee.;Byung Soo Kwan.;Kwang Min Kim.;Sang Goon Shim.;Jung Won Lee.;Jun Young Kim.;Bo Ram Sung.;Hye In Kim.;Seung Hwan Kim.
来源: BMC Gastroenterol. 2025年25卷1期289页
Endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) is a widely utilized and relatively safe procedure for diagnosing pancreatic diseases. Although early feeding post-EUS-FNB is clinically advantageous, consensus regarding the optimal feeding time in current guidelines remains lacking. Therefore, this study aims to evaluate the efficacy and safety of early feeding after EUS-FNB.
|